Fluorescent Imaging Agents for Brain Diseases
Targets · 2023
DOI: 10.3390/targets1010003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Targets, 2023. Verfasst von Feida Che und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Shandong Province, National Science Foundation of Shandong Province of China.
Abstract (Originalsprache)
The onset of brain diseases has a terrible impact on people’s lives, including brain tumors, Alzheimer’s disease, Parkinson’s disease, depression, and schizophrenia. Thus, the diagnosis and treatment of various brain disorders have been receiving specific attention. The fluorescence imaging technique is useful for examining brain diseases because it is intuitive, in situ, and real-time. Therefore, fluorescent imaging has so far been successfully employed to identify molecules associated with brain disease. In this review, the last five years of research advancements in fluorescent imaging agents for the above diseases are summarized, and the creation of pertinent fluorescence probes is described and prospected.
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Shandong Province
- National Science Foundation of Shandong Province of China
Zitieren
APA
Che, F., Zhao, X., Wang, X., Li, P., & Tang, B. (2023). Fluorescent Imaging Agents for Brain Diseases. Targets. https://doi.org/10.3390/targets1010003
Vancouver
Che F, Zhao X, Wang X, Li P, Tang B. Fluorescent Imaging Agents for Brain Diseases. Targets. 2023. doi:10.3390/targets1010003
BibTeX
@article{Che2023,
author = {Che, Feida and Zhao, Xiaoming and Wang, Xin and Li, Ping and Tang, Bo},
title = {Fluorescent Imaging Agents for Brain Diseases},
journal = {Targets},
year = {2023},
doi = {10.3390/targets1010003}
}
EUVIMED